Top related persons:
Top related locs:
Top related orgs:

Search resuls for: "Rick Wise"


5 mentions found


Goldman Sachs — Goldman Sachs shares jumped 3.3% in premarket trading after the company beat Wall Street's first-quarter earnings expectations . Goldman posted earnings of $11.58 per share on revenue of $14.21 billion for the period, fueled by its trading and investment banking businesses. Analysts surveyed by LSEG had called for earnings of $8.56 per share on revenue of $12.92 billion, meanwhile. Analyst Erik Woodring thinks the market is "mis-pricing" Logitech's outlook and forecasts only 3% annual revenue growth through fiscal year 2027. Masimo — The health tech stock rose more than 2% following an upgrade to buy from hold at Stifel.
Persons: Goldman Sachs — Goldman Sachs, Wall, Goldman, LSEG, Morgan Stanley, Erik Woodring, Masimo, Rick Wise, there's, Lockheed Martin, Tal Liani, Canaccord Genuity, Coty, Charles Schwab —, Schwab, Elon Musk, — CNBC's Brian Evans, Michelle Fox, Sarah Min, Pia Singh Organizations: Logitech —, Stifel, Wall Street Journal, Reuters, Informatica, Medical Properties, Citi, Lockheed, JPMorgan, Cisco Systems —, Bank of America, Splunk, Coty —, Revenue, Resideo Technologies Locations: Utah, South Korea
Meanwhile, Canaccord Genuity initiated Coty with a buy rating and a price target that implied more than 30% upside. The firm initiated coverage of the restaurant chain stock with an equal weight rating and a $58 per share price target. The firm upgraded shares of the health technology company to buy from hold in a Sunday note and increased its target price to $178 from $140. The firm downgraded the computer peripherals maker to underweight from equal weight and lowered its price target to $75 per share from $85. The firm initiated coverage of the online forum stock with an equal weight rating and a $45 per share price target.
Persons: Morgan Stanley, Canaccord Genuity, Coty, Cava's, Jeffrey A, Bernstein, — Brian Evans, Jensen Huang, Atif Malik, Raimo Lenschow, Brian Evans, Masimo, MASI, Rick Wise, Logitech Morgan Stanley, Morgan Stanley's, Erik Woodring, Reddit, Morgan, Brian Nowak, Nowak, Canaccord, Susan Anderson, Anderson, COTY, Fred Imbert Organizations: CNBC, Barclays, Cava, Citi, Nvidia Citi, Nvidia, NVIDIA, Microsoft, Logitech, Coty, COTY Locations: Friday's, Cava, Taiwan, U.S
To that effect, here are five attractive dividend stocks, according to Wall Street's top experts on TipRanks, a platform that ranks analysts based on their past performance. The analyst increased his price target for Verizon stock by $1 to $40, while maintaining AT&T's price target at $17. Also, he expects the prospects for improved free cash flow to lower net debt leverage and support the dividend payments. That said, with expectations of higher cash flow generation, Crum said that "the company should have more flexibility around growing its dividend going forward." (See Hasbro Stock Chart on TipRanks)Dell TechnologiesNext up is Dell (DELL), a maker of IT hardware and infrastructure technology, which rallied after its fiscal second-quarter results far exceeded Wall Street's estimates.
Persons: Hans Vestberg, Brendan McDermid, Wall, Michael Rollins, Rollins, MDT, Rick Wise, Geoff Martha, Wise, Drew Crum, Crum, TipRanks, Amit Daryanani, Daryanani, Dell Organizations: DELL, Verizon, New York Stock Exchange, Analysts, Verizon Communications, Citi, AT, Verizon Hedge, Hasbro, Dell Technologies, Dell, TipRanks, GPU, Walmart, &' $ Locations: New York, U.S
Feb 21 (Reuters) - Medtronic Plc (MDT.N) said on Tuesday it expects inflation in various markets to hit its profit in the next fiscal year after the medical device maker beat earnings estimate for the third quarter on strong demand for its heart and diabetes devices. While inflation in many countries has eased in recent months, the management expects a delayed improvement in its earnings as its costs remain high. "VBP has affected us more than many of our competitors, given the size and breadth of our business in China. Stifel analyst Rick Wise expects Medtronic to get past pricing pressure in China in "the not too distant future". Reporting by Leroy Leo and Mariam E Sunny in Bengaluru; Editing by Maju SamuelOur Standards: The Thomson Reuters Trust Principles.
[1/2] The company logo for Johnson & Johnson is displayed to celebrate the 75th anniversary of the company's listing at the New York Stock Exchange (NYSE) in New York, U.S., September 17, 2019. J&J is focused on its pharmaceuticals and medical devices operations with the consumer health spinoff expected by November 2023. Chief Executive Joaquin Duato has said he will look to build up the medical devices unit through acquisition. Abiomed will operate as a standalone business within the healthcare conglomerate's medical technology division. J&J's medical technology business includes surgical, orthopedic and various other devices.
Total: 5